EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 14 filers reported holding EVAXION BIOTECH A S in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,035 | -18.3% | 19,500 | +30.1% | 0.00% | – |
| Q4 2022 | $26,973 | -98.2% | 14,985 | -97.3% | 0.00% | – |
| Q3 2022 | $1,486,000 | +67.7% | 565,009 | +24.5% | 0.00% | – |
| Q2 2022 | $886,000 | +13.2% | 453,986 | +76.9% | 0.00% | – |
| Q1 2022 | $783,000 | +14.8% | 256,650 | +66.1% | 0.00% | – |
| Q4 2021 | $682,000 | – | 154,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ground Swell Capital, LLC | 18,071 | $32,528 | 0.14% |
| Telemetry Investments, L.L.C. | 37,500 | $68 | 0.11% |
| Beacon Capital Management, LLC | 6,881 | $12,214 | 0.00% |
| PURA VIDA INVESTMENTS, LLC | 16,842 | $29,895 | 0.00% |
| MORGAN STANLEY | 3,696 | $6,560 | 0.00% |
| Citadel Advisors | 13,000 | $23,400 | 0.00% |
| Citadel Advisors | 500 | $900 | 0.00% |
| Citadel Advisors | 1,485 | $2,673 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 41,600 | $74,880 | 0.00% |
| UBS Group AG | 5,081 | $9,044 | 0.00% |